ABL tyrosine kinase activity controls several aspects of development including axon patterning.
INTRODUCTION
Tumorigenesis and neurodegeneration may be two sides of the same coin. Indeed, defining the overlap of molecular pathways implicated in cancer and neurodegeneration may open the door to novel therapeutic approaches for both groups of disorders (Staropoli, 2008) . Interestingly, it has been proposed that, in the non-pathologic physiological situation, the neurodegenerative Amyloid precursor protein (APP) recruits the oncogenic Abelson (Abl) kinase in order to promote axonal outgrowth (Soldano et al., 2013) . Correlative studies have highlighted a decreased cancer incidence in the neurodegenerative disorder Huntington's disease (HD) population and both wildtype and mutant huntingtin (HTT) have been implicated in tumor progression (Thion and Humbert, 2018) . It is, therefore, tempting to propose that different neurodegenerative diseases (ND) may share components and mechanisms and that Abl may also have a role in ND.
The Abl-family of non-receptor tyrosine kinase includes human ABL1 and ABL2 as well as the Drosophila Abl, all of which share a conserved domain structure along much of the protein.
Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette which confers autoregulated kinase activity. Particularly, in these three proteins a carboxy-terminal F (F-actin-binding) domain is identifiable which ties ABL-dependent phosphoregulation to actin filament reorganization (Colicelli, 2010) . ABL1 has been implicated to function in a range of cellular processes including actin dynamics and cell migration. ABL was discovered as a cellular proto-oncogene co-opted by the Abelson Murine Leukemia Virus, as well as part of the Breakpoint Cluster Region (BCR)-ABL oncoprotein which is constitutively active in human chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) (Wang, 2014) . Alterations of ABL1 by chromosomal rearrangement or viral transduction can lead to malignant transformation. Activity of the ABL1 protein is negatively regulated by its SH3 domain, 3 secondary (auto)phosphorylation (Brasher and Van Etten, 2000) . The ABL kinases have also been shown to play a crucial role in the development of the nervous system. Overexpression of active Abl in adult mouse neurons results in neurodegeneration and neuroinflammation and activation of ABL has been shown to occur in human neurodegenerative disease (Schlatterer et al., 2011) .
Drosophila Abl has a role in axonogenesis and growth cone motility and, of particular relevance here, Abl has been implicated in axonal arborization and growth in the Drosophila brain (Leyssen et al., 2005) .
The adult central brain of Drosophila is largely composed of the central complex and the mushroom bodies (MBs). MBs are bilateral and symmetrical structures that are required for learning and memory (Heisenberg, 2003; Busto et al., 2010) . Each MB is made of 2000 neurons that arise from 4 neuroblasts whose larval development is known through use of specific markers.
Three types of neurons appear sequentially during development: the embryonic/early larval γ, the larval α'β' and the late larval/pupal αβ. Each αβ neuron projects an axon that branches to send an α branch dorsally, which contributes to the formation of the α lobe, and a β branch medially, which contributes to the formation of the β lobe .
APPs have been intensely investigated because of their link to Alzheimer's disease and neurodegeneration, although the normal in vivo function of APPs in the brain remains unclear and controversial. Drosophila possesses a single APP homologue, called APPL, expressed in all neurons throughout development. It has been shown that Appl is a conserved neuronal modulator of a Wnt planar cell polarity (Wnt/PCP) pathway involved in MB axonal outgrowth (Soldano et al., 2013) . It has been proposed that APPL is part of the membrane complex formed by the core PCP receptors. In turn, APPL recruits ABL kinase to the complex and positively modulates DSH phosphorylation . DSH is an adaptor cytoplasmic protein apparently involved in all known Wnt pathways and, as such, is also a core intracellular component of the Wnt/PCP pathway. It was showed that a 50% reduction of Abl leads to a clear enhancement of the Appl d mutant phenotype. Conversely, wild-type Abl + overexpression (UAS-Abl) but not UAS-Abl-KD (the kinase dead version) within the αβ MB neurons led to a strong rescue of the Appl d mutant phenotype. Finally, these results, in addition to accompanying biochemical experiments, suggested that APPL regulates the phosphorylation of DSH by ABL kinase and that this mechanism is conserved in mammals (Soldano et al., 2013) . Thus, ABL is the key downstream effector of APPL required for MB axon outgrowth.
Huntington's disease (HD) is a progressive autosomal dominant, neurodegenerative disorder caused by the expansion of a polyglutamine (polyQ) tract at the N-terminus of a large cytoplasmic protein (3144 a.a.), huntingtin (HTT) (Saudou and Humbert, 2016) . Several studies indicate that an alteration of wild-type HTT function might also contribute to disease progression (Cattaneo et al., 2005) . The fly huntingtin protein (HTT, 3583 a.a.) is similar to the human HTT protein, with four regions of high sequence homology clustered similarly all along the protein in the N-, central-and C-terminal regions. Despite htt being highly conserved across all Drosophila species, indicating an essential role for biological fitness, null htt mutants show no obvious developmental defects (Zhang et al., 2009) .
Although ABL is the key downstream effector of APPL required for MB axon outgrowth, its precise role in MB development is poorly documented. Here we show, using analysis of Abl loss-of function (LOF) alleles in single-cell MARCM clones that Abl is essentially required for axonal growth in the developing αβ neurons of the MBs and that it is expressed in these neurons.
Importantly, the overexpression of Abl in these neurons leads to similar axonal growth defects to those observed with the LOF allelic combinations, indicating the probable existence of cellular proteins that negatively control neuronal ABL activity. We identify HTT as a potential cellular inhibitor of ABL activity. These results indicate that Appl and htt, whose human homologs are central players in neurodegeneration, regulate ABL activity in opposite directions to maintain it in the narrow range necessary for normal axon outgrowth.
RESULTS

Loss-of-function and gain-of-function of Abl induce similar MB αβ neuron phenotype
Abl is a component of an APPL Wnt-PCP signaling pathway required for axon growth in MBs (Soldano et al., 2013) . Nevertheless, the precise role of Abl in MB neurons is poorly described.
We have used three Abl alleles (Abl 1 , Abl 2 and Abl 4 ) in order to characterize the requirement of Abl function in MB development ( Fig. S1A ). Each of three double heterozygous combinations (1/2, 2/4 and 1/4) are adult lethal but are viable at 48 hr after puparium formation (APF) enabling their effects to be investigated at that stage when the αβ neurons are present and can be easily visualized using the anti-Fasciclin II (FASII) antibody Reynaud et al., 2015) .
Interestingly, the three combinations gave similar MB phenotypes with a mixture of wild-type (WT), absence of β lobe, absence of α lobe and absence of α and β lobes ( Fig. 1A-D ). Control MBs showed less than 0.5% of absence of β lobe ( n=402 with 99.5% of the MBs being WT, data not shown). These Abl mutant phenotypes, including lethality, were strongly rescued in the presence of an Abl-GFP genomic construct (from 20%, n=115 to more than 80%, n=48 of WT MBs p < 10 -5 ; Fig. 1D ). Abl is known to be deleterious when expressed in an unregulated fashion (Schlatterer et al., 2011; Wang, 2014) . We overexpressed Abl specifically in the MBs using the GAL4/UAS system (Brand and Perrimon, 1993) . WT Abl overexpression in the MBs under the control of the OK107-GAL4 line, produced similar phenotypes to those obtained in Abl LOF alleles ( Fig. 1E ; Fig   S1B-E) . The penetrance of the gain-of-function (GOF) mutant phenotype was even higher than the one obtained with LOF alleles since WT MBs were never detected. Importantly, when a kinase dead version of the Abl gene was expressed in the same conditions, no MB mutant phenotype was apparent. This indicates that over-activity of the kinase function of ABL is causing the phenotype.
Taken together, these data strongly show that Abl expression must be tightly controlled in the MBs in order to ensure normal MB axon development.
Abl function is required for MB axon outgrowth and is expressed in MB αβ neurons
The absence of MB lobes can result from either growth or guidance defects (Soldano et al., 2013; Reynaud et al., 2015) . In order to definitively establish which of these two cellular phenomena is affected by loss of Abl we produced visualization MARCM clones. Abl mut two-cell/single cell visualization MARCM clones showed growth defects (87% n = 15) as well as guidance defects (20%) ( Table 1 and Fig. 1F -I'). Therefore, we conclude that Abl, as Appl, is required for MB axon outgrowth. To visualize the localization of ABL protein we employed a genomic Abl-GFP construct, which rescues Abl mutant lethality and the mutant MB phenotypes (see above) and therefore is likely a bona fide endogenous marker of ABL. Abl-GFP is expressed broadly and homogenously in the brain with elevated levels in the MB αβ axons of 48 hours APF brains ( Fig.   1J -J"). Taken together, these data show that Abl is expressed in the MBs and that Abl function is required for MB axon outgrowth.
The lack of htt rescues MB axon outgrowth phenotypes
Since LOF and GOF of Abl produce similar MB phenotypes, its expression must be tightly controlled during normal development. We were therefore interested in isolating potential cellular inhibitors that negatively regulate Abl activity in the Drosophila MBs. Due to the recessive nature 6 of the Abl mutant phenotype and the autosomal location of the gene, we considered looking directly for suppressors to be too laborious. We therefore took advantage of the previous observation that ABL kinase acts downstream of APPL in MB axon growth (Soldano et al., 2013) . Flies which are null for Appl (Appl d ) are viable, fertile and show no gross structural defects in the brain (Luo et al., 1992) . The loss of one copy of Abl combined with Appl d (in Appl d w*/Y; Abl 4 /+ males) increases the MB lobe loss phenotype compared to Appl d alone, while overexpression of Abl in MB neurons rescues the Appl d phenotype (Soldano et al., 2013) . We reasoned that a suppressor of Abl activity could also be a suppressor of other components of the Wnt-PCP pathway required for MB axon outgrowth, such as Appl and dsh for which hemizygous viable mutations are available (Appl d and dsh 1 ).Therefore, the MB phenotype can be directly assayed in Appl d males. Fly HTT is a cytoplasmic ubiquitous protein expressed at low levels (Zhang et al., 2009 ). We identified htt as a clear suppressor of the MB Appl d mutant phenotype. The Appl d MB phenotype was rescued by reducing htt expression using three different genetic manipulations: 1) htt heterozygosity using two mutant alleles of htt (htt-ko or htt int ), 2) heterozygosity for a 55 kb chromosomal deficiency uncovering the htt locus and most of the adjacent CG9990, or 3) htt RNAi knock down in the αβ MB neurons ( Fig. 2A-E ). We noted that loss of one or even two copies of htt did not result in any significant MB developmental defects ( Fig. S2A ). However, we found that reducing one copy of htt suppressed also the dsh 1 MB phenotype . Hemizygosity for both Appl and dsh (using a double mutant Appl d w dsh 1 chromosome) resulted in a strong MB axon outgrowth phenotype (up to 60% absence of β lobe, n=129 compared to 21%, n=101 p < 10 -5 in dsh 1 and to 16%, n=141 p < 10 -5 in Appl d ). We found that reducing htt was also a strong suppressor of the Appl d w dsh 1 phenotype (12% of absence of β lobe, n=68 p < 10 -5 ; Fig. 2 H-I and J). Taken together, these data strongly suggest that HTT is a negative regulator of the Wnt-PCP signaling pathway acting during MB axon outgrowth.
htt interacts with Abl mutant phenotype in MB axon outgrowth
We found that both the Appl d and dsh 1 MB phenotypes can be rescued by Abl expression ( Fig. S2B and C). Taken together with the finding that htt suppresses both Appl and dsh MB phenotypes, we hypothesized that Abl might be the target of htt action. To test this hypothesis we conducted three sets of experiments. First, the increased severity of the MB mutant phenotype in Appl d ; Abl 2 /+ individuals (31% of absence of β lobe, n=102) compared to Appl d individuals (14% of absence of β lobe, n=100 p=0.0041), was completely abolished when one copy of htt was also removed in Appl d ; Abl 2 htt int /+ individuals (14% absence of β lobe, n=83 with p=0.0089 when compared to Appl d ; Abl 2 /+ individuals and p=1 when compared to Appl d individuals; Fig. 3A ). Second, a modest but significant increase in the proportion of WT MBs in Abl 2 /Abl 1 individuals was observed when one dose of htt was also removed (from 20%, n=222 to 32%, n=215 p=0.0086; Fig. 3B ; Fig. S3 see discussion). Third, a clear increase of the Abl GOF mutant phenotype, measured by the absence of both α and β lobes, was seen when one dose of htt was removed (from 21%, n=87 to 75%, n=79 p < 10 -5 ; Fig. 3C upper and middle panel). Conversely, a clear rescue of this phenotype was observed when htt was also overexpressed using UAS-htt-fl-CTAP, a UAS-C-terminally TAPtagged full length htt (from 21%, n=87 to 5%, n=77 p=0.005; Fig. 3C upper and lower panel).
Furthermore, the presence of wild-type MBs in these individuals is a strong indication of an interaction between htt and Abl (from 0%, n=87 compared to 9%, n=77 p=0.0043; Fig. 3C last panel). As expected from these results, expressing UAS-htt-fl-CTAP was able to abolish the rescuing effect of htt int /+ on Appl d males (16% of absence of β lobe in Appl d ; UAS-htt-fl-CTAP/+; htt int /+ males , n=120 with p=0.0003 when compared to 2% of absence of β lobe in Appl d ; +/+; htt int /+ males, n=107 and p=0.8672 when compared to 17% of absence of β lobe in Appl d males, n=138) showing its functionality ( Fig. 4A ). Also, UAS-htt-fl-CTAP was properly expressed in the MBs (Fig. 4B ). The ability of htt/+ to suppress the Abl LOF phenotype or to enhance the Abl GOF phenotype as well as the ability of htt overexpression to suppress the Abl GOF phenotype seem to correlate with the amount of kinase-competent residual protein in the various mutant settings (see discussion). Taken together, these data strongly further indicates that HTT is a repressor of ABL function during MB axon outgrowth.
Reduction of htt increases ABL kinase activity in the developing MBs
One hypothesis to explain the suppressor effect of the lack of one dose of htt on the Abl MB mutant phenotype is that HTT may have an inhibitory role on ABL kinase activity. A fluorescence resonance energy transfer (FRET) biosensor probe that allows ABL kinase activity to be assayed in living cells was recently introduced and validated in Drosophila (Kannan et al., 2017) . Using this tool, we first showed that the ABL kinase activity is detectable in the MBs by comparing the FRET activity of the UAS-Abl-FRET versus the FRET activity of a mutant that lacks its phosphorylatable tyrosine UAS-YàF Abl-FRET (Fig. 5A-C and E; Fig. S4 ). We then tested the FRET efficiency in the developing MBs of control (+/+) versus htt int /+ larvae and detected a clear increase of the FRET efficiency when one dose of htt was removed ( Fig. 5D and F). Quantitative PCR analysis of control versus htt int /+ third instar larval brains showed no difference in Abl mRNA expression ( Fig. 5G) . Also, the htt/+ heterozygous background does not seem to result in any apparent differences in either the quantity or the localization of ABL protein in the MBs (Fig.   6 ). Finally, reduced HTT expression does not affect the total levels of neuronal ABL in Drosophila heads ( Fig. S5 ). Taken together, these data strongly suggest that HTT is a repressor of ABL kinase activity in the developing MB axons.
DISCUSSION
Abl is a key component of the Appl signaling pathway required for axonal arborization and growth in the fly brain and the functional relationship between these two proteins is likely conserved in mammals (Leyssen et al., 2005; Soldano et al., 2013) . While the role of APP-mediated signaling has been most clearly shown in Drosophila, a number of lines of evidence suggest that mammalian APP also fulfills a signaling role (Beckett et al., 2012) . Importantly, and in line with its protooncogenic role, Abl tyrosine kinase activity is tightly regulated by intramolecular inhibition (Barila and Superti-Furga, 1998) . Although Abl is clearly required as a downstream effector of Appl in the MB axon growth, its precise role and regulation in the MBs has not been described.
We show here that Abl is required in axonal growth in the MBs, a brain structure that is involved in memory. Furthermore, we show that both Abl overexpression and lack of expression in the MBs produce similar phenotypes, indicating the need for tight regulation of ABL activity during MB axon outgrowth. This raises the question of how ABL activity is normally negatively regulated during MB axon outgrowth. We confirmed the previous observation that forced expression of Abl rescues the Appl d MB phenotypes (Soldano et al., 2013) . Furthermore, we found that Abl overexpression also rescues the dsh 1 MB phenotype. These two results support the model that APPL activates ABL, which in turn phosphorylates DSH ( Fig. S2B and C) . At the genetic level, we expected an increase of ABL activity in an individual bearing LOF allele(s) of a putative Abl repressor. We therefore hypothesized that reducing the levels of an Abl repressor would result in suppression of the Appl and dsh mutant MB phenotype. We found that HTT is such a potential inhibitor of ABL activity in the MBs. The loss of one dose of htt increased the activity of the wildtype ABL still present in Abl 2 /+ individuals and therefore prevented the enhancement of the MB mutant phenotype (Fig. 3A) . While a number of studies have concluded that HTT deficiency results in significant alterations to kinase signaling pathways, to our knowledge this study is the first to implicate the crucial phosphotyrosine kinase, ABL (Bowles and Jones, 2014) .
The three Abl alleles used in this study are all have been shown to result in truncated proteins (Smith and Liebl, 2005) . While Abl 1 retains the SH3, SH2 and TK domain of the ABL, Abl 2 is mutated within the TK domain and retains the SH3 and SH2 domains and Abl 4 , which is mutated in the SH2 domain, retains the SH3 domain but completely lacks the TK domain ( Fig.   S1A ). It, therefore, seems likely that very little or no wild type Abl function remains in Abl 2 /Abl 4 and Abl 4 /Abl 1 individuals and can possibly explain why no rescue was observed when one dose of htt was removed in these genetic backgrounds (Fig. S3 ). Conversely, since Abl 1 /Abl 2 animals express truncated ABL proteins, this allelic combination is likely less severe than the other two genotypes. Indeed, while significant amounts of truncated Abl 1 and Abl 2 mutant proteins are detectable, only faint protein bands are observed in Abl 4 pupae (Bennett and Hoffmann, 1992) .
Therefore, some significant kinase activity could remain in Abl 2 /Abl 1 individuals and the loss of one dose of htt might increase the activity of the remaining kinase activity (Fig. 3B ). Finally, removing one dose of htt in animals overexpressing ABL ( There are three different levels at which HTT might act to modulate Abl activity. First, HTT could either directly or indirectly effect Abl mRNA levels. Although fly HTT has been described as a cytoplasmic protein (Zhang et al., 2009) , htt has been shown to be a suppressor of position-effect variegation, suggesting a role in chromatin organization (Dietz et al., 2015) . This hypothesis is unlikely for the MB phenotype described here since qRT-PCR analysis of third instar brains did not reveal a significant difference in Abl mRNA levels between htt int /+ and control individuals ( Fig. 5G ). Second, HTT could play a role in the quantity/stability or the localization of the ABL protein in the MBs. We also consider this unlikely since the quantity of the endogenous protein and the increased localization at the tip of the α lobes observed when UAS-Abl is driven by c739-GAL4 are not different in htt int /+ versus control individuals (Fig. 6 ). Third, HTT could have an effect on the kinase activity of ABL itself. A FRET biosensor that allowed us to assay ABL kinase activity directly in the MBs showed a clear increase in htt int /+ versus control individuals ( Fig. 5 ). Therefore, we favor the model that HTT acts as an inhibitor of ABL kinase activity during normal development.
The HEAT repeat domains of HTT may function as a solenoid-like structure that acts as a scaffold and mediates inter-and intra-molecular interactions. Other arguments in favor of HTT being a molecular scaffold are its large size and its stability (Saudou and Humbert, 2016) . It is tempting to propose that the scaffolding role of HTT in necessary for ABL kinase activity repression. At least in the MBs, a balance between the activity of ABL, positively regulated by the membrane complex formed by the core PCP proteins and APPL, and the repression of ABL activity, which includes HTT might exist. On one hand, if APPL is absent, ABL is not optimally activated leading to defects in MB axon growth. Conversely, when only 50% of HTT is present this leads to de-repression of Abl kinase activity, which in turn compensates for its sub-optimal level of activation in the absence of Appl. This unexpected apparent balance of activation and inhibition of Abl by Appl and htt, whose orthologs are central players in human disease, may define a conserved functional interaction to maintain ABL activity in the relatively narrow window to appropriately effect axon outgrowth.
MATERIALS AND METHODS
Drosophila Stocks
All crosses were maintained on standard culture medium at 25 o C. Except where otherwise stated, all alleles and transgenes have been described previously (http://flystocks.bio.indiana.edu/). The following alleles were used: Abl 1 , Abl 2 , Abl 4 , Appl d , dsh 1 , htt int (Dietz et al., 2015) , htt-ko and Dfhtt (Zhang et al., 2009 ). The following transgenes were used: UAS-Abl (#28993), UAS-Abl.K417N (from #8566) named here UAS-Abl KD for kinase dead, UAS-RNAi-htt (Gunawardena et al., 2003) , UAS-RNAi-htt v29351 and UAS-RNAi-htt v29532 (VDRC), UAS-mCD8GFP, UAS-mito-GFP, UAS-FRT-y + -FRT and the genomic construct Abl-GFP (Fox and Peifer, 2007) . UAS-htt-fl-CTAP was produced for this study (see Constructs). We used three GAL4 lines: c739-GAL4 expressed in αβ MB neurons, OK107-GAL4 expressed in all MB neurons (Aso et al., 2009) and the pan-neuronal driver elav c155 -GAL4. Recombinant chromosomes were obtained by standard genetic procedures and were molecularly checked when required.
Adult and Pupal Brain Dissection and Immunostaining
Adult brains were dissected in PBS after fly heads and thoraxes had been fixed for 1hr in 3.7% formaldehyde in PBS. They were then treated for immunostaining as previously described Boulanger et al., 2011) . Pupal brains were dissected in PBS and fixed for 20min in 3.7% formaldehyde in PBS at 4 o C with gentle rocking. After washing twice in PBS with 0.5% Triton X-100 (PBT) for 15 min at room temperature, they hey were incubated in PBT and 5% bovine serum albumin (BSA) (blocking solution) at room temperature for 30 min, followed by overnight incubation at 4 o C with primary antibody diluted in blocking solution. Brains were then washed three times in PBS for 20 min, followed by 30 min in the blocking solution, and then addition of the secondary antibody with incubation for 3 hr at 4 o C. Brains were then washed three times in PBS for 20 min and were mounted with Vectashield (Vector Laboratories). Antibody combinations used: anti-Fasciclin II (mAb 1D4 from DSHB) at 1:50 dilution followed by antimouse Cy3 (Jackson ImmunoResearch) at 1:300; rabbit anti-MYC (Cell Signaling) at 1:1000 followed by anti-rabbit Cy5 (Jackson ImmunoResearch) at 1:300; mouse anti-TAP (Santa Cruz Biotechnology) at 1:300 followed by anti-mouse Cy3 (Jackson ImmunoResearch) at 1:300.
MARCM Clonal Analysis
To generate clones in the MB, we used the MARCM technique . For single and two-cell clones, late L3 larvae were heat-shocked at 37 o C for 15 min. Brains were dissected at 48 hr APF and then stained. We use the term "visualization MARCM clones" since homozygous mutant clones were examined in a homozygous mutant background.
Microscopy and Image Processing
Images were acquired at room temperature using a Zeiss LSM 780 laser scanning confocal microscope (MRI Platform, Institute of Human Genetics, Montpellier, France) equipped with a 40x PLAN apochromatic 1,3 oil-immersion differential interference contrast objective lens. The immersion oil used was Immersol 518F. The acquisition software used was Zen 2011. Contrast and relative intensities of the green (GFP), red (Cy3) and blue (Cy5) channels were processed with Fiji Software. Quantitation was performed using ImageJ software.
Constructs
pUAS-htt-fl-CTAP: A full length htt "mini-gene" bearing a dual C-terminal Tandem Affinity Purification tag (Protein G and a streptavidin binding peptide: GS-TAP tag) was constructed. PCR was performed using the dhtt "mini-gene" comprising the dhtt cDNA with intron 10 (as described in Dietz et al., 2015) and the following primers:
HTT-TAP-FOR: ggtaccATGGACAAATCCAGGTCCAG (KpnI site added) and HTT-TAP-REV: tctagaCAGGCACTGCAACATCCGG (XbaI site added). The resulting PCR product was digested with KpnI/XbaI and sublconed into the pUAST-CTAP(SG) vector (Kyriakakis et al., 2008) . To avoid rearrangements due to dhtt instability, culturing conditions were used as previously described (Dietz et al., 2015) . pUAS-htt-fl-CTAP transgenic flies were generated and balanced using standard procedures and expression of dhtt-SG was assessed using western blots.
FRET Imaging
Fly brains were dissected in 1X PBS at room temperature and collected in ice-cold PBS before being fixed in 3.6% formaldehyde for 20 min. Brains were rinsed twice in PBST 0.5X for 20 min before being mounted in Vectashield® (Vector Laboratories). MBs were imaged using a LSM780 confocal microscope (Zeiss) at x40 with oil immersion and on adjacent 0.5 µm confocal planes along the anterior-posterior axis. Cyan fluorescent protein (CFP) was excited at 405 nm and emission recorded between 454 and 500 nm. Yellow fluorescent protein (YFP) was excited at 514 nm and emission recorded between 516 and 571 nm. Fluorescence resonance energy transfer (FRET) was generated at 405 nm. To avoid CFP emission, FRET was recorded out of CFP emission range, between 587 and 624 nm.
FRET image analysis
Brains were oriented anterior-posteriorly using the peduncle as an anatomical landmark and aligned according to the first confocal plane where a signal was visible. We ensured that the same number of planes were obtained for each group (c739>Abl-FRET: 48 ± 4 planes and c739>(YàF) Abl-FRET: 46 ± 1.5 planes, Student t-test: p=0,7. c739>Abl-FRET: 79,3 ± 2,3 planes and c739; htt int >Abl-FRET: 75,4 ± 3,7 planes; Student t-test: p=0,4) indicating that there were no differences due to mounting. Average YFP and FRET signals were computed using the measurement of 'Mean Grey Value' and the 'Plot Z-axis Profile' functions of ImageJ (Schneider et al., 2012) into a region of interest (ROI) corresponding to the contour of the MB and for each confocal plane. Background was corrected using the 'Rolling Ball Background Subtraction' function (50 px radius). For each plane and within the same ROI, FRET signal was expressed relative to YFP to account for variability in Abl-FRET biosensor expression level or differences between preparations. Only groups (i.e. Abl-FRET vs (YàF) Abl-FRET and Abl-FRET vs htt int ;Abl-FRET) crossed, collected, dissected and imaged on the same day were compared. For any given confocal plane, FRET ratio was averaged on left and right MBs and multiple animals.
qRT-PCR
To quantify Abl expression, RNA was extracted from the brains of L3 males. Brains (~20/sample) were dissected in PBS 1X (Sigma) and kept on ice before homogenized in TRIzol® reagent (Ambion). Total RNA was treated with DNAse to eliminate genomic DNA (TURBO DNasefree TM , Applied Biosystems). RNA was purified using phenol-chloroform extraction and first strand cDNA synthesis was performed using SuperScript TM III reverse transcriptase (Invitrogen).
Primers for Abl RNA amplification were designed on each side of intron 4-5 within exon 4 and 5 respectively. These exons are present in all Abl transcripts. Abl primers were designed using Primer3Plus online software and using the qPCR settings (Untergasser et al., 2012) . Abl forward primer sequence is 5'-GCGGCCATCATGAAGGAAATG-3' and reverse primer sequence is 5'-TTGCCGTGCGACATAAACTC-3'. Abl RNAs were real-time quantified using incorporation of SYBRGreen (Roche) and Light Cycler (Roche). Primers efficacy was first evaluated using a range of cDNA concentrations to ensure linearity of the amplification (E=1,944). Only one melting temperature (Tm=81,6°C) was obtained corresponding to a single PCR product (Abl amplicon).
The amplicon was run on a gel to ensure the size was the one expected for Abl after splicing (107 bp). A control without reverse transcription was done to ensure that Abl amplicon was not obtained (Tm≠81.6°C). For each sample, a technical triplicate was performed and averaged. Independent biological replicates were prepared for each condition and the fold change averaged (see Statistics). The biological replicates correspond to independent dissections, extractions, reverse transcriptions and quantifications. In the experimental condition (y w 67c23 /Y; ; htt int /+), Abl expression was expressed relative to control flies (y w 67c23 /Y) after normalization with internal controls, Rpl9 and Rpl32, and using the ∆∆CT method (Livak and Schmittgen, 2001) .
Western blotting and immunoprecipitations
Lysates of adult Drosophila heads were prepared using RIPA buffer supplemented with protease inhibitors (Sigma #11836170001). Antibodies used for immunoprecipitation were: anti-GFP (mouse, HTZ 19C8 and 19F7, Memorial-Sloan Kettering Monoclonal Antibody Facility; (Heiman et al., 2014) ), anti-dAbl (rabbit, 1:500; (Song et al., 2010) ). Antibodies used for immunoblotting with dilutions were: anti-dhtt (3526, rabbit polyclonal, 1:1,000; (Dietz et al., 2015) ), anti-dAbl (as above, 1:1,000), anti-GFP (rabbit, Invitrogen #A-11122, 1:1,000), anti-b-Tubulin (mouse, DSHB E7, 1:10,000), anti-mouse and anti-rabbit IRDye secondary antibodies (LI-COR Biosciences, 1:10,000). Immunoprecipitations were performed in RIPA buffer incubated with 1µg of anti-GFP or 2µg of anti-dAbl. Immunocomplexes were precipitated with either Protein A and Protein G Sepharose beads (anti-GFP), or Protein A Sepharose beads (anti-dAbl) for 1h at 4°C before washing three times with RIPA buffer. Protein A and Protein G Sepharose beads were from Amersham Biosciences. Lysates and immunoprecipitates were resolved on NuPAGE 3-8% gradient Tris-Acetate gels with Tris-Acetate running buffer. After transfer to nitrocellulose membranes, blots were processed according to the Odyssey CLx protocol.
Statistics
Comparison between two groups expressing a qualitative variable was analyzed for statistical significance using the Fisher exact test (https://www.socscistatistics.com/tests/fisher/Default2. aspx). Comparison of two groups expressing a quantitative variable was analyzed using the two- Wild-type MB α and β lobes revealed by anti-FASII staining. (B-D) Anti-FASII staining reveals the absence of the β lobe in an Appl d mutant brain (B), which is rescued by the loss of one copy of htt (C) and is also rescued by the expression of RNAi against htt driven by c739-GAL4 (D). (E) Quantitation of rescue of the MB Appl d phenotype by Df-htt, htt-ko, htt int and UAS-RNAi-htt driven by c739-GAL4. n = number of MBs analyzed and *** p < 0.001 (Fisher exact test). Note that the rescue of Appl d by htt int was done as an independent experiment. Statistics were done from its own Appl d control, for which the phenotype of β lobe absence was 14% (n = 106; p = 0.0008). (F-G) Anti-FASII staining reveals the absence of β lobe in a dsh 1 mutant brain (F), which is rescued by the loss of one copy of htt (G). (H-I) Anti-FASII staining reveals the loss of the two β lobes in an Appl d dsh 1 mutant brain (H), which is rescued by the loss of one copy of htt (I). (J) Quantitation of the rescue of dsh 1 and of Appl d dsh 1 phenotypes by htt-ko. n = number of MBs analyzed and *** p < 0.001 (Fisher exact test). All panels correspond to adult brains. The scale bar on panels A-D and F-I indicates 30 µm. Images are composite stacks to allow the visualization of axon trajectories along their entire length. Full genotypes are listed in supplemental information for Fig.2.   Fig. 3 . htt interacts with Abl mutant phenotype. (A) The Appl d mutant phenotype is enhanced in an Abl 2 heterozygote mutant background. However, the Appl d mutant phenotype is not modified in an Abl 2 htt int double heterozygote mutant background. Note that these two experiments were done independently, but for both of them the Appl d mutant phenotype was 14% of β lobe absence.
(B) The Abl 2 /Abl 1 mutant phenotype is partially rescued by the loss of one copy of htt as inferred by the increase of the wild-type (WT) MBs. (C) The absence of α and β lobe phenotype observed in UAS-Abl driven by OK107-GAL4 is strongly increased by the loss of one copy of htt. However, this phenotype is rescued by the overexpression of full-length htt. The presence of WT MBs in this genotype is also a strong indication of rescue. n = number of MBs analyzed and ** p < 0.01, *** p < 0.001 (Fisher exact test). All panels correspond to adult brains except for B which is from 48 hr APF brains. Full genotypes are listed in supplemental information for Fig.3.   Fig. 4. UAS-htt- Note that Appl d w; htt int is also in Fig. 2E. (B-B" Table 1 .
Supplemental information for
Genotypes
Control: w * tubP-GAL80 hs-FLP122 FRT19A / w * sn FRT19A; c739-GAL4 UAS-mCD8-GFP / UAS-mCD8-GFP. Abl 2 /Abl 4 : w * tubP-GAL80 hs-FLP122 FRT19A / w * sn FRT19A; c739-GAL4 UAS-mCD8-GFP / UAS-mCD8-GFP; Abl 2 / Abl 4 . Fig. S1, related to Fig. 1. Structure and overexpression (C) top to bottom: w dsh 1 / Y. w dsh 1 / Y; Abl-GFP / +. Fig. S3, related to Fig. 3 . htt interaction with Abl.
The loss of one copy of htt does not rescue the Abl 4 /Abl 1 or Abl 2 /Abl 4 mutant phenotype. All panels correspond 48 hr APF brains. Genotypes: top to bottom: y w 67c23 ; ; Abl 4 FRT2A / Abl 1 FRT2A . y w 67c23 ; ; Abl 4 FRT2A htt int / Abl 1 FRT2A . y w 67c23 ; ; Abl 2 FRT2A / Abl 4 FRT2A . y w 67c23 ; ; Abl 2 FRT2A htt int / Abl 4 FRT2A . Fig. S4, related to Fig. 5 . The lack of htt releases Abl-FRET biosensor phosphorylation. 
